Author:
Mukhtar Maowia M.,Eisawi Omer A.,Amanfo Seth A.,Elamin Elwaleed M.,Imam Zeinab S.,Osman Faiza M.,Hamed Manasik E.
Abstract
Abstract
Background
Plasmodium vivax infection is rising in sub-Saharan Africa, where Plasmodium falciparum is responsible for more than 90% of malaria cases. While P. vivax is identified as a major cause of severe and cerebral malaria in South east Asia, the Pacific and South America, most of the severe and cerebral cases in Africa were attributed to P. falciparum. Cases of severe malaria due to P. vivax are emerging in Africa. A few severe P. vivax cases were reported in Eastern Sudan and they were underestimated due to the lack of accurate diagnosis, low parasitaemia and seldom use of rapid diagnostic tests (RDTs).
Case presentation
A 60-year-old Sudanese male presented to the Al Kuwaiti hospital in the Sudan capital Khartoum. On admission, the patient was complaining of fever (measured temperature was 38 °C), sweating, chills, vomiting and confusion in the past 2 days prior to his admission. He rapidly deteriorated into a coma state within 48 h of the admission, with significant neck stiffness. He was admitted to the intensive care unit and was suspected of meningitis. Lumbar puncture was not performed since the patient was suffering from spinal cord disc. Brain CT scan was unremarkable. Several biochemical, haematological tests, and blood film for malaria were performed. The results of the laboratory tests were within the normal range except of mild elevation of the total white blood cell count and a significant decrease in the platelets count. Malaria parasites were seen in the blood film with high parasitaemia (quantified as 3 +++). The patient was diagnosed as P. vivax cerebral malaria based on the positive blood film and the amplification of P. vivax specific 499 bp amplicon using Plasmodium multi-species multiplex Polymerase Chain Reaction (PCR). The patient was treated with quinine 10 mg/kg body weight for 10 days followed by primaquine 15 mg/days PO for 2 weeks. The symptoms subsided within 48 h and the patients was cured and released from the hospital.
Conclusions
Plasmodium vivax is an emerging cause of cerebral malaria in adults in Sudan and should be considered in the differential diagnosis of cerebral malaria for proper management of patients.
Funder
National Institute for Health Research
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference10 articles.
1. World Health Organization. Severe malaria. Trop Med Int Health. 2014;19(Suppl 1):7–131.
2. WHO. Control and elimination of Plasmodium vivax malaria. A technical brief. Geneva: World Health Organization; 2015.
3. Elgoraish AG, Elzaki SEG, Ahmed RT, Ahmed AI, Fadlalmula HA, Abdalgader Mohamed S, et al. Epidemiology and distribution of Plasmodium vivax malaria in Sudan. Trans R Soc Trop Med Hyg. 2019.
https://doi.org/10.1093/trstmh/trz044
(Epub ahead of print).
4. Rayis DA, Ahmed MA, Omer EM, Adam I. Plasmodium vivax malaria among pregnant women in Eastern Sudan. Asian Pacific J Trop Dis. 2016;6:2021–3.
5. Abdallah TM, Abdeen MT, Ahmed IS, Hamdan HZ, Magzoub M, Adam I. Severe Plasmodium falciparum and Plasmodium vivax malaria among adults at Kassala Hospital, eastern Sudan. Malar J. 2013;12:148.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献